Gu Andrew bought CLRB
July 7, 2026 · Form 4 insider transaction
Gu Andrew bought 25,000 shares of Cellectar Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderGu Andrew
Role—
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 7, 2026
Filing dateJuly 8, 2026
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date.